Press briefing on EU recommendation for COVID-19 Vaccine AstraZeneca

• Date:
  Friday, 29 January 2021, All day
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

This virtual press briefing will discuss the outcome of the evaluation of COVID-19 Vaccine AstraZeneca by EMA’s human medicines committee (CHMP).

Speakers include:

• Emer Cooke (EMA's Executive Director)
• Bruno Sepodes (CHMP Vice-chair)
• Sabine Straus (PRAC Chair)
• Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy).

Marie-Agnes Heine, EMA's Head of Communication, will moderate the press briefing.

The press briefing is held in English. 

Video recording